ClinConnect ClinConnect Logo
Search / Trial NCT05600205

Evaluation of Combined Support for the Ambulatory Lifestyle Intervention

Launched by GGZ CENTRAAL · Oct 26, 2022

Trial Information

Current as of July 24, 2025

Not yet recruiting

Keywords

Ambulatory Implementation Effectiveness

ClinConnect Summary

This clinical trial is studying a new support program called GOAL! designed for people with severe mental illnesses (SMI), like schizophrenia, bipolar disorder, or severe anxiety. Many individuals with SMI face higher risks for health issues such as heart disease and diabetes, which can significantly shorten their lifespan and impact their quality of life. GOAL! offers a personalized approach where qualified professionals help participants improve their lifestyle over an extended period, focusing on their individual needs and challenges. The goal is to see if this program can effectively support those with SMI in living healthier lives.

To participate in this trial, individuals must be at least 18 years old and currently receiving treatment for a severe mental illness. They should also have specific health concerns, such as being at risk for metabolic syndrome, which includes issues like high blood pressure or abnormal cholesterol levels. However, those who are unable to give consent or are experiencing severe symptoms that prevent participation will not be included. This trial is not yet recruiting participants, but it aims to evaluate how well the GOAL! program works and how it can be implemented in the community to better support people with SMI.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age or older;
  • Diagnosed with a severe mental illness (SMI; defined as within treatment of a FACT team);
  • Excessive abdominal circumference (≥102 cm for men or ≥ 88 cm for women; this is one of five risk factors for metabolic syndrome);
  • Presence of at least one of the other four risk factors as clustered in the criteria for metabolic syndrome (hypertension, abnormal triglycerides, fasting blood sugar and HDL cholesterol, or medication use for blood pressure or values).
  • Exclusion Criteria:
  • If someone lacks the legal capacity to give independent consent for participation and no (legal) representative is willing to give consent;
  • If the disease severity at that time does not permit participation (i.e. acute psychological state, acute psychosis, or suicidality).

About Ggz Centraal

GGZ Centraal is a leading mental health care organization in the Netherlands, dedicated to providing comprehensive and innovative treatment solutions for individuals facing mental health challenges. With a commitment to research and clinical excellence, GGZ Centraal actively engages in clinical trials to advance the understanding and effectiveness of mental health treatments. The organization fosters collaboration among healthcare professionals, researchers, and patients to enhance therapeutic outcomes and contribute to the broader field of psychiatric care. Through its rigorous research initiatives, GGZ Centraal aims to improve patient care and promote evidence-based practices in mental health.

Locations

Amersfoort, Utrecht, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials